Face masks don’t restrict oxygen or contribute to carbon dioxide buildup: study
The study was conducted after a group of Florida residents challenged Florida’s mask-wearing mandate in June. — FOX News: Jeanette Settembre
The study was conducted after a group of Florida residents challenged Florida’s mask-wearing mandate in June. — FOX News: Jeanette Settembre
House Speaker Nancy Pelosi revealed Friday she’s been tested for coronavirus out of an “abundance of caution” and raised concerns about the accuracy of tests at the White House that “led to” President Trump’s exposure. — FOX News: Marisa Schultz
San Francisco 49ers running back Raheem Mostert appeared to be upset over the rash of injuries that were occurring at MetLife Stadium on Thursday night during the New York Jets and Denver Broncos’ game. — FOX News: Ryan Gaydos
Bella Hadid showed off her killer figure on the runway for Rihanna’s Savage X Fenty Vol. 2 show. — FOX News: Naledi Ushe
What next for President Trump, his campaign and the U.S government, now that he himself has contracted the virus after downplaying the risk for months? The president tweeted he and the first lady tested positive. The president’s positive test result came
Judge Amy Coney Barrett, President Trump’s Supreme Court nominee, last had direct contact with President Trump on Saturday as Trump officially announced her nomination, according to the White House. — FOX News: Tyler Olson
Fellowship program honors Dr. Just, a pioneering biologist and one of the most prominent African American scientists of the twentieth century WASHINGTON & PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #UNCF–The UNCF and Bristol Myers Squibb (NYSE: BMY) today announced the second cohort of the Ernest
“Letters” Film Showcases How FAR’s People-Focused Approach is Making Retirement Work for Customers and Inspires First Major Television Spot SAN DIEGO–(BUSINESS WIRE)–Finance of America Reverse LLC (“FAR”), one of the largest reverse mortgage lenders in the U.S. and a leading provider of
Researchers Will Present Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination with Doravirine, and Phase 1/1b Data for MK-8507, an Investigational NNRTI for the Treatment of HIV-1 Infection Company Plans to Advance MK-8507 into Phase 2 Evaluating its Efficacy